Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent
- 10 July 2014
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 33 (6) , 813-819
Abstract
Patients with lymph node-positive urothelial carcinoma of the bladder generally have a poor prognosis. Nevertheless, long-term survival in up to 30 % of patients is reported. In the absence of established prognostic molecular markers, an assessment of the prognosis with clinical parameters is mandatory. All patients from one high-volume center with a curatively intended cystectomy for lymph node-positive urothelial carcinoma were evaluated. Patients’ overall and cancer-specific survival were correlated with clinicopathological parameters. Pathological lymph node staging was performed with both the 2002 and 2010 TNM classification of the AJCC. Lack of a perioperative chemotherapy (p < 0.001), higher numbers of positive nodes (p = 0.002), a higher lymph node density (p = 0.003), a higher pathological T stage (p = 0.006) and urinary diversion with an ileal conduit compared to an ileal neobladder (p = 0.023) were prognostic of a shorter overall survival while the number of removed lymph nodes showed no significant association with survival. Both with the 2002 and 2010 TNM classifications patients staged pN1 had a longer overall survival and time to cancer-specific death in comparison to patients with more extensive lymph node disease. According to the 2002 classification, there was a significant survival difference between patients with lymph node metastases in regional and distant lymph nodes. Patients with a low lymph node density and an early pT stage present with the best prognosis among LN positive patients. The value of perioperative chemotherapy is emphasized. Which lymph node metastases are to be considered regional or distant remains a matter of debate.Keywords
This publication has 19 references indexed in Scilit:
- Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node MetastasisEuropean Urology, 2013
- Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node–Positive Disease after Radical CystectomyEuropean Urology, 2012
- Lymph Node Density Affects Cancer-Specific Survival in Patients with Lymph Node–Positive Urothelial Bladder Cancer Following Radical CystectomyEuropean Urology, 2011
- Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: Analysis by the number of lymph nodes removedUrologic Oncology: Seminars and Original Investigations, 2011
- Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?World Journal of Urology, 2011
- The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder CancerEuropean Urology, 2009
- Evaluation of the Relevance of Lymph Node Density in a Contemporary Series of Patients Undergoing Radical CystectomyJournal of Urology, 2006
- Adjuvant Cisplatin Plus Methotrexate Versus Methotrexate, Vinblastine, Epirubicin, and Cisplatin in Locally Advanced Bladder Cancer: Results of a Randomized, Multicenter, Phase III Trial (AUO-AB 05/95)Journal of Clinical Oncology, 2005
- Risk Factors for Patients With Pelvic Lymph Node Metastases Following Radical Cystectomy With En Bloc Pelvic Lymphadenectomy: The Concept of Lymph Node DensityJournal of Urology, 2003
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996